Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...

The xx have been back in the studio together since early last year, too, and it seems the band is still hard at work on the follow-up to 2017’s I See You. Below, check out those pics and footage ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...

New music from The xx could be on the way, with the trio having confirmed they have been "in the studio" together. Posted on Saturday (March 8) with the caption "Last week, in the studio", the three ...

Moderna has been hit by massive insider selling over the last couple of years. The stock has a 52-week high of over $170 while Moderna entered 2020 trading below $20, making insiders more likely ...

Moderna, Inc.'s stock surged 16% yesterday after a German court ruled Pfizer and BioNTech may have violated Moderna's COVID-19 vaccine patent, potentially leading to compensation. Despite the ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Moderna Inc.’s stock tumbled 4% Thursday after a report that health officials are reviewing a contract the company won from the Biden administration to support efforts to develop a bird-flu ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...